Provider
P51R1-17 Updated: Accountable Care Organization Product and Network Name Changes
Program effective Date: Nov 15, 2017
Search Results
Displaying 2671 - 2680 of 4269 results
Provider
P60-17 2018 Renewal Changes Summary for Institutional Providers
Program effective Date: Nov 01, 2017
Provider
P61-16 New Drug-Related Prior Authorization Criteria for Amitiza and Linzess
Program effective Date: Dec 13, 2016
Provider
P52-16 DHS Guidelines for Mental Health-Targeted Case Management Services for MHCP Subscribers
Program effective Date: Nov 04, 2016
Provider
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Program effective Date: Nov 06, 2017
Provider
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Program effective Date: Dec 20, 2016
Provider
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Program effective Date: Jun 05, 2017
Provider
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Oct 24, 2017
Provider
P39-17 Concurrent Review for Inpatient Hospital Services at Select Facilities
Program effective Date: Jul 11, 2017
Provider
P62-16 EY Modifier for Platinum Blue Subscribers
Program effective Date: Dec 13, 2016